Liu M, Chen P, Wei B, Tan H, Zhao Y, Ai L
Sci Rep. 2025; 15(1):327.
PMID: 39747903
PMC: 11695688.
DOI: 10.1038/s41598-024-83369-5.
Liu Y, Song Y, He Y, Kong Z, Li H, Zhu Y
Endocrine. 2024; 87(2):648-657.
PMID: 39266883
DOI: 10.1007/s12020-024-04026-5.
Tabiti H, Guensi A, Bendahhou K
Cureus. 2024; 16(1):e52033.
PMID: 38344552
PMC: 10853663.
DOI: 10.7759/cureus.52033.
Kim M, Park H, Oh Y, Shin J, Kim T, Hahn S
Korean J Radiol. 2024; 25(1):103-112.
PMID: 38184773
PMC: 10788599.
DOI: 10.3348/kjr.2023.0461.
Mu Z, Zhang X, Sun D, Sun Y, Shi C, Ju G
J Clin Endocrinol Metab. 2023; 109(5):1231-1240.
PMID: 38060243
PMC: 11031230.
DOI: 10.1210/clinem/dgad697.
Risk factors associated with preferential lateral lymph node metastasis in papillary thyroid carcinoma.
Shao L, Wang Z, Dong W, Sun W, Zhang H
Cancer Med. 2023; 12(22):20670-20676.
PMID: 37905599
PMC: 10709716.
DOI: 10.1002/cam4.6567.
RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis.
Bulanova Pekova B, Sykorova V, Mastnikova K, Vaclavikova E, Moravcova J, Vlcek P
Endocr Relat Cancer. 2023; 30(12).
PMID: 37882481
PMC: 10620462.
DOI: 10.1530/ERC-23-0117.
Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma in a patient with Hashimoto's thyroiditis: a case report and literature review.
Li J, He S, Xu J, Xue G
Front Oncol. 2023; 13:1248830.
PMID: 37869091
PMC: 10585257.
DOI: 10.3389/fonc.2023.1248830.
Surgical strategy for patients with papillary thyroid carcinoma invading the trachea: a comparison of tracheal sleeve resection with end-to-end anastomosis and window resection with tracheocutaneous fistula.
Inoue Y, Ebina A, Toda K, Shimbashi W, Yamada K, Mitani H
Gland Surg. 2023; 12(9):1167-1178.
PMID: 37842530
PMC: 10570975.
DOI: 10.21037/gs-23-171.
A clinically useful and biologically informative genomic classifier for papillary thyroid cancer.
Craig S, Stretch C, Farshidfar F, Sheka D, Alabi N, Siddiqui A
Front Endocrinol (Lausanne). 2023; 14:1220617.
PMID: 37772080
PMC: 10523308.
DOI: 10.3389/fendo.2023.1220617.
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective.
Pitoia F, Scheffel R, Califano I, Gauna A, Tala H, Vaisman F
Rev Endocr Metab Disord. 2023; 25(1):109-121.
PMID: 37380825
DOI: 10.1007/s11154-023-09818-0.
Distant Metastasis as the First Presentation of Thyroid Carcinoma.
Talebpour M, Mahmoudabadi H, Najjari K, Hajebi R, Rahimpour E, Bahreini M
Indian J Otolaryngol Head Neck Surg. 2023; 75(2):1020-1023.
PMID: 37275079
PMC: 10235276.
DOI: 10.1007/s12070-022-03343-3.
Nomogram for preoperative prediction of high-volume lymph node metastasis in the classical variant of papillary thyroid carcinoma.
Feng H, Chen Z, An M, Chen Y, Chen B
Front Surg. 2023; 10:1106137.
PMID: 36843997
PMC: 9945534.
DOI: 10.3389/fsurg.2023.1106137.
Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.
Omi Y, Haniu K, Kamio H, Fujimoto M, Yoshida Y, Horiuchi K
World J Surg Oncol. 2022; 20(1):394.
PMID: 36510206
PMC: 9743747.
DOI: 10.1186/s12957-022-02869-8.
Risk factor score for the prediction of central compartment lymph node metastasis in papillary thyroid carcinoma and its clinical significance.
Pan X, Li Q
Front Surg. 2022; 9:914696.
PMID: 36420408
PMC: 9676942.
DOI: 10.3389/fsurg.2022.914696.
Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.
Vallejo Casas J, Sambo M, Lopez Lopez C, Duran-Poveda M, Rodriguez-Villanueva Garcia J, Santos R
Eur Thyroid J. 2022; 11(5).
PMID: 35900793
PMC: 9422238.
DOI: 10.1530/ETJ-21-0111.
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.
Pacilio M, Conte M, Frantellizzi V, De Feo M, Pisani A, Marongiu A
Diagnostics (Basel). 2022; 12(7).
PMID: 35885666
PMC: 9320760.
DOI: 10.3390/diagnostics12071763.
APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.
Siraj S, Masoodi T, Siraj A, Azam S, Qadri Z, Parvathareddy S
Cancers (Basel). 2022; 14(6).
PMID: 35326735
PMC: 8946015.
DOI: 10.3390/cancers14061584.
Predictors of Response to Therapy Among Post Thyroidectomy Adult Filipino Patients with Papillary Thyroid Carcinoma Based on the 2015 American Thyroid Association Guidelines.
Santiago A, Isidro M, Parra J
J ASEAN Fed Endocr Soc. 2021; 36(2):161-166.
PMID: 34966200
PMC: 8666484.
DOI: 10.15605/jafes.036.02.18.
Effect of Prophylactic Central Lymph Node Dissection on Locoregional Recurrence in Patients with Papillary Thyroid Microcarcinoma.
Yang P, Li J, Jing H, Chen Q, Song X, Qian L
Int J Endocrinol. 2021; 2021:8270622.
PMID: 34819955
PMC: 8608519.
DOI: 10.1155/2021/8270622.